Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatology Case Report: When Moyamoya Disease Mimicks Primary Central Nervous System Vasculitis

Joey Kim, MD, Megha Patel-Banker, MD, Matthew Abramson, MD, Mehwish Bilal, MD, Sanjay Godhwani, MD, Asha Patnaik, MD, Heidi Roppelt, MD, & Qingping Yao, MD  |  Issue: November 2015  |  November 16, 2015

Moyamoya, meaning a “hazy puff of smoke” in Japanese, is a chronic, occlusive cerebrovascular disease involving bilateral stenosis or occlusion of the terminal portion of the internal carotid arteries (ICA) and/or the proximal portions of the anterior cerebral arteries (ACA) and middle cerebral arteries (MCA) that leads to neurological deficits.

Epidemiology

CNS vasculitis was first seen and described from autopsy results in the 1950s and, at that time, was described as granulomatous angiitis. Recent estimates indicate that the annual incidence of PACNS is around 2.4 per million people. Although it has been reported in both children and adults, it is more commonly seen in men from 30–50 years old.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Moyamoya disease was first described in Japanese literature in 1957 by Takaku and Suzuki.2 It is most commonly found in Asian populations. The incidence of moyamoya disease is highest in Japan with approximately three cases per 100,000 persons, which is 30–40 times higher than in the U.S., where the incidence is approximately 0.086 cases per 100,000 persons. Unlike in PACNS, moyamoya disease is more common in females, with the peak ages of incidence in children at 5 years old and adults in their 40s.3

Clinical Presentation

Figure 4: A repeat MRI of the brain two weeks after the initial MRI revealed a new lacunar infarct of the left corona radiata and the old infarct in the right posterior occipito-parietal lobe.

Figure 4: A repeat MRI of the brain two weeks after the initial MRI revealed a new lacunar infarct of the left corona radiata and the old infarct in the right posterior occipito-parietal lobe.

PACNS often has a long prodromal period and is thought to rarely present with acute manifestations. In a review of 116 patients, 83% presented with a change in mental status, 56% with headaches, 30% with seizures, 14% with stroke and 12% with cerebral hemorrhage.4

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Clinical presentation of moyamoya disease differs between adults and children. Adults typically present with transient or permanent cerebral infarction and intracranial hemorrhage; however, children present mainly with ischemic events. Although patients can present without any symptoms, patients more often will present with visual deficits, speech disturbances, headaches, intellectual deterioration, cranial nerve palsies and/or gait disturbances.3

Diagnosis

In PACNS, 80–90% of patients have abnormal CSF findings characterized by elevated total protein concentrations.7 Inflammatory markers, such as ESR and CRP, are typically normal, as are ANCA and ANA.

Although imaging of the head is usually nonspecific, the most common findings are infarcts. The infarcts can involve any part of the subcortical white matter, deep gray matter, deep white matter or the cerebral cortex. Angiography is often used as a diagnostic test, although its specificity and sensitivity are very low and, therefore, cannot be used as a sole determinant of the etiology of the patient’s symptoms. Typical findings, however, include alternating areas of narrowing and dilation of the arteries, which can give the vessels a beaded appearance. Other diagnostic features include arterial occlusion of many cerebral arteries without atherosclerosis or other abnormalities, but in the end, the gold standard for diagnosis of PACNS continues to be a brain biopsy. Histopathology will often show either a granulomatous, lymphocytic or necrotizing vasculitis.3

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:case reportcentral nervous systemDiagnosismoyamoyapatient carerheumatologyTreatmentVasculitis

Related Articles

    Case Report: Lymphocytic Vasculitis of the Central Nervous System

    January 17, 2019

    Vasculitis is a group of chronic inflammatory diseases in which the blood vessel is the target of an immune reaction. They can be secondary to connective tissue disease, idiopathic or due to infection, neoplasm or drugs.1 Primary angiitis of the central nervous system (PACNS) is a rare syndrome characterized by inflammatory cell infiltration and necrosis…

    Meet the Lumbar Spinal Stenosis Challenge

    August 1, 2007

    Limited evidence and diagnostic options make this increasing condition difficult to treat

    7 Key Insights Into the Evaluation of Central Nervous System Vasculitis

    May 13, 2021

    Many a rheumatology consult has centered on a perplexing question: Does this patient have central nervous system (CNS) vasculitis? At the 2021 ACR State-of-the-Art Clinical Symposium, Rula Hajj-Ali, MD, FACP, professor of medicine and associate director of vasculitis care and research, Cleveland Clinic Lerner College of Medicine, discussed this topic in detail, providing a series…

    Meet the Challenge of Primary CNS Vasculitis

    September 1, 2011

    Diagnosis and treatment of this rare and poorly understood condition

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences